HomeCompareELVAY vs EQR

ELVAY vs EQR: Dividend Comparison 2026

ELVAY yields 42.97% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ELVAY wins by $224.4K in total portfolio value
10 years
ELVAY
ELVAY
● Live price
42.97%
Share price
$1.16
Annual div
$0.50
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$272.2K
Annual income
$48,798.02
Full ELVAY calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — ELVAY vs EQR

📍 ELVAY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodELVAYEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ELVAY + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ELVAY pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELVAY
Annual income on $10K today (after 15% tax)
$3,652.28/yr
After 10yr DRIP, annual income (after tax)
$41,478.32/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, ELVAY beats the other by $36,824.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELVAY + EQR for your $10,000?

ELVAY: 50%EQR: 50%
100% EQR50/50100% ELVAY
Portfolio after 10yr
$160.0K
Annual income
$27,136.81/yr
Blended yield
16.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

ELVAY
No analyst data
Altman Z
-116.1
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELVAY buys
0
EQR buys
0
No recent congressional trades found for ELVAY or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricELVAYEQR
Forward yield42.97%5.87%
Annual dividend / share$0.50$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$272.2K$47.8K
Annual income after 10y$48,798.02$5,475.61
Total dividends collected$209.0K$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ELVAY vs EQR ($10,000, DRIP)

YearELVAY PortfolioELVAY Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$14,997$4,296.80$11,380$679.82+$3.6KELVAY
2$22,069$6,022.27$13,014$837.25+$9.1KELVAY
3$31,896$8,282.42$14,961$1,036.20+$16.9KELVAY
4$45,316$11,187.46$17,297$1,289.22+$28.0KELVAY
5$63,343$14,854.72$20,121$1,613.15+$43.2KELVAY
6$87,183$19,405.55$23,561$2,030.84+$63.6KELVAY
7$118,247$24,961.63$27,783$2,573.54+$90.5KELVAY
8$158,165$31,640.94$33,013$3,284.39+$125.2KELVAY
9$208,791$39,553.64$39,547$4,223.51+$169.2KELVAY
10$272,204$48,798.02$47,791$5,475.61+$224.4KELVAY

ELVAY vs EQR: Complete Analysis 2026

ELVAYStock

Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.

Full ELVAY Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this ELVAY vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELVAY vs SCHDELVAY vs JEPIELVAY vs OELVAY vs KOELVAY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.